Literature DB >> 22215666

Interleukin 33 as a mechanically responsive cytokine secreted by living cells.

Rahul Kakkar1, Hillary Hei, Stephan Dobner, Richard T Lee.   

Abstract

Interleukin 33 (IL-33), a member of the Interleukin 1 cytokine family, is implicated in numerous human inflammatory diseases such as asthma, atherosclerosis, and rheumatoid arthritis. Despite its pathophysiologic importance, fundamental questions regarding the basic biology of IL-33 remain. Nuclear localization and lack of an export signal sequence are consistent with the view of IL-33 as a nuclear factor with the ability to repress RNA transcription. However, signaling via the transmembrane receptor ST2 and documented caspase-dependent inactivation have suggested IL-33 is liberated during cellular necrosis to effect paracrine signaling. We determined the subcellular localization of IL-33 and tracked its intracellular mobility and extracellular release. In contrast to published data, IL-33 localized simultaneously to nuclear euchromatin and membrane-bound cytoplasmic vesicles. Fluorescent pulse-chase fate-tracking documented dynamic nucleo-cytoplasmic flux, which was dependent on nuclear pore complex function. In murine fibroblasts in vitro and in vivo, mechanical strain induced IL-33 secretion in the absence of cellular necrosis. These data document IL-33 dynamic inter-organelle trafficking and release during biomechanical overload. As such we recharacterize IL-33 as both an inflammatory as well as mechanically responsive cytokine secreted by living cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22215666      PMCID: PMC3307313          DOI: 10.1074/jbc.M111.298703

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Multicolor and electron microscopic imaging of connexin trafficking.

Authors:  Guido Gaietta; Thomas J Deerinck; Stephen R Adams; James Bouwer; Oded Tour; Dale W Laird; Gina E Sosinsky; Roger Y Tsien; Mark H Ellisman
Journal:  Science       Date:  2002-04-19       Impact factor: 47.728

2.  Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload.

Authors:  Tuanzhu Ha; Yuehua Li; Fang Hua; Jinag Ma; Xiang Gao; Jim Kelley; Aiqiu Zhao; Georges E Haddad; David L Williams; I William Browder; Race L Kao; Chuanfu Li
Journal:  Cardiovasc Res       Date:  2005-06-20       Impact factor: 10.787

3.  Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload.

Authors:  James T Colston; William H Boylston; Marc D Feldman; Chris P Jenkinson; Sam D de la Rosa; Amanda Barton; Rodolfo J Trevino; Gregory L Freeman; Bysani Chandrasekar
Journal:  Biochem Biophys Res Commun       Date:  2007-01-16       Impact factor: 3.575

4.  Specific covalent labeling of recombinant protein molecules inside live cells.

Authors:  B A Griffin; S R Adams; R Y Tsien
Journal:  Science       Date:  1998-07-10       Impact factor: 47.728

Review 5.  Roles of chromatin insulator proteins in higher-order chromatin organization and transcription regulation.

Authors:  Jutta Vogelmann; Alessandro Valeri; Emmanuelle Guillou; Olivier Cuvier; Marcello Nollmann
Journal:  Nucleus       Date:  2011-09-01       Impact factor: 4.197

6.  Mechanical deformation promotes secretion of IL-1 alpha and IL-1 receptor antagonist.

Authors:  R T Lee; W H Briggs; G C Cheng; H B Rossiter; P Libby; T Kupper
Journal:  J Immunol       Date:  1997-11-15       Impact factor: 5.422

7.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

Authors:  Jochen Schmitz; Alexander Owyang; Elizabeth Oldham; Yaoli Song; Erin Murphy; Terril K McClanahan; Gerard Zurawski; Mehrdad Moshrefi; Jinzhong Qin; Xiaoxia Li; Daniel M Gorman; J Fernando Bazan; Robert A Kastelein
Journal:  Immunity       Date:  2005-11       Impact factor: 31.745

8.  IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.

Authors:  Virginie Carriere; Lucie Roussel; Nathalie Ortega; Delphine-Armelle Lacorre; Laure Americh; Luc Aguilar; Gérard Bouche; Jean-Philippe Girard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-21       Impact factor: 11.205

9.  Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.

Authors:  Mei Sun; Manyin Chen; Fayez Dawood; Urszula Zurawska; Jeff Y Li; Thomas Parker; Zamaneh Kassiri; Lorrie A Kirshenbaum; Malcolm Arnold; Rama Khokha; Peter P Liu
Journal:  Circulation       Date:  2007-03-12       Impact factor: 29.690

Review 10.  Pathogenesis of ventricular hypertrophy.

Authors:  S Oparil
Journal:  J Am Coll Cardiol       Date:  1985-06       Impact factor: 24.094

View more
  121 in total

1.  Poor Repair of Skeletal Muscle in Aging Mice Reflects a Defect in Local, Interleukin-33-Dependent Accumulation of Regulatory T Cells.

Authors:  Wilson Kuswanto; Dalia Burzyn; Marisella Panduro; Kathy K Wang; Young Charles Jang; Amy J Wagers; Christophe Benoist; Diane Mathis
Journal:  Immunity       Date:  2016-02-09       Impact factor: 31.745

2.  Alternative splicing of interleukin-33 and type 2 inflammation in asthma.

Authors:  Erin D Gordon; Laura J Simpson; Cydney L Rios; Lando Ringel; Marrah E Lachowicz-Scroggins; Michael C Peters; Agata Wesolowska-Andersen; Jeanmarie R Gonzalez; Hannah J MacLeod; Laura S Christian; Shaopeng Yuan; Liam Barry; Prescott G Woodruff; K Mark Ansel; Karl Nocka; Max A Seibold; John V Fahy
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-18       Impact factor: 11.205

3.  Interleukin-33 induces growth-regulated oncogene-α expression and secretion in human umbilical vein endothelial cells.

Authors:  Masayoshi Yamamoto; Katsuyuki Umebashi; Akinori Tokito; Junichi Imamura; Michihisa Jougasaki
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2017-06-21       Impact factor: 3.619

4.  Dynamic role of epithelium-derived cytokines in asthma.

Authors:  Kathleen R Bartemes; Hirohito Kita
Journal:  Clin Immunol       Date:  2012-03-20       Impact factor: 3.969

Review 5.  Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy.

Authors:  Michal Heger; Rowan F van Golen; Mans Broekgaarden; Renate R van den Bos; H A Martino Neumann; Thomas M van Gulik; Martin J C van Gemert
Journal:  Lasers Med Sci       Date:  2014-03       Impact factor: 3.161

6.  Increased density of intraepithelial mast cells in patients with exercise-induced bronchoconstriction regulated through epithelially derived thymic stromal lymphopoietin and IL-33.

Authors:  Ying Lai; William A Altemeier; John Vandree; Adrian M Piliponsky; Brian Johnson; Cara L Appel; Charles W Frevert; Dallas M Hyde; Steven F Ziegler; Dirk E Smith; William R Henderson; Michael H Gelb; Teal S Hallstrand
Journal:  J Allergy Clin Immunol       Date:  2013-11-09       Impact factor: 10.793

7.  Elevated circulating sST2 associated with subclinical atherosclerosis in newly diagnosed primary hypertension.

Authors:  Ihsan Ates; Nihal Ozkayar; Hale Ates; Uğur Nadir Karakulak; Oğuzhan Kursun; Canan Topcuoglu; Bayram Inan; Nisbet Yilmaz
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

8.  Distinct immunocyte-promoting and adipocyte-generating stromal components coordinate adipose tissue immune and metabolic tenors.

Authors:  Raul German Spallanzani; David Zemmour; Tianli Xiao; Teshika Jayewickreme; Chaoran Li; Paul J Bryce; Christophe Benoist; Diane Mathis
Journal:  Sci Immunol       Date:  2019-05-03

9.  Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity.

Authors:  Noah W Palm; Rachel K Rosenstein; Shuang Yu; Dominik D Schenten; Esther Florsheim; Ruslan Medzhitov
Journal:  Immunity       Date:  2013-10-24       Impact factor: 31.745

10.  IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling.

Authors:  Melissa Y Tjota; Jesse W Williams; Tiffany Lu; Bryan S Clay; Tiara Byrd; Cara L Hrusch; Donna C Decker; Claudia Alves de Araujo; Paul J Bryce; Anne I Sperling
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.